Oxford brain health clinic: protocol and research database.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
04 08 2023
Historique:
medline: 7 8 2023
pubmed: 5 8 2023
entrez: 4 8 2023
Statut: epublish

Résumé

Despite major advances in the field of neuroscience over the last three decades, the quality of assessments available to patients with memory problems in later life has barely changed. At the same time, a large proportion of dementia biomarker research is conducted in selected research samples that often poorly reflect the demographics of the population of patients who present to memory clinics. The Oxford Brain Health Clinic (BHC) is a newly developed clinical assessment service with embedded research in which all patients are offered high-quality clinical and research assessments, including MRI, as standard. Here we describe the BHC protocol, including aligning our MRI scans with those collected in the UK Biobank. We evaluate rates of research consent for the first 108 patients (data collection ongoing) and the ability of typical psychiatry-led NHS memory-clinic patients to tolerate both clinical and research assessments. Our ethics and consenting process enables patients to choose the level of research participation that suits them. This generates high rates of consent, enabling us to populate a research database with high-quality data that will be disseminated through a national platform (the Dementias Platform UK data portal).

Identifiants

pubmed: 37541753
pii: bmjopen-2022-067808
doi: 10.1136/bmjopen-2022-067808
pmc: PMC10407419
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e067808

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: CEM is a cofounder and shareholder of Exprodo Software, which was used to develop the BHC database. CEM serves on a Biogen Brain Health Consortium (unpaid). No other competing interests to report.

Références

Neuroimage Clin. 2022;36:103273
pubmed: 36451375
Neurology. 2010 Jan 19;74(3):201-9
pubmed: 20042704
J Gen Intern Med. 2009 Jul;24(7):783-8
pubmed: 19247718
N Engl J Med. 2023 Jan 5;388(1):9-21
pubmed: 36449413
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
Eur J Epidemiol. 2020 Jun;35(6):601-611
pubmed: 32328990
Alzheimers Dement. 2015 Jul;11(7):734-9
pubmed: 26194309
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Alzheimers Res Ther. 2017 Oct 26;9(1):85
pubmed: 29070066
Psychol Med. 1989 Nov;19(4):1015-22
pubmed: 2594878
Dement Geriatr Cogn Disord. 2013;36(3-4):242-50
pubmed: 23949210
Alzheimers Dement. 2017 May;13(5):561-571
pubmed: 27931796
Health Qual Life Outcomes. 2020 Nov 30;18(1):375
pubmed: 33256754
Lancet. 2015 Jun 6;385(9984):2255-63
pubmed: 25771249
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
J Alzheimers Dis. 2018;62(3):1091-1111
pubmed: 29562540
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Nat Neurosci. 2016 Nov;19(11):1523-1536
pubmed: 27643430
BJPsych Bull. 2022 Dec;46(6):315-321
pubmed: 34782030
Int J Geriatr Psychiatry. 2007 Jan;22(1):61-7
pubmed: 16988960

Auteurs

Melissa Clare O'Donoghue (MC)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Jasmine Blane (J)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Grace Gillis (G)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Robert Mitchell (R)

Oxford Health NHS Foundation Trust, Oxford, UK.

Karen Lindsay (K)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Juliet Semple (J)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Pieter M Pretorius (PM)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Ludovica Griffanti (L)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Jane Fossey (J)

Oxford Health NHS Foundation Trust, Oxford, UK.
College of Medicine and Health, University of Exeter, Exeter, UK.

Vanessa Raymont (V)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Lola Martos (L)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Health NHS Foundation Trust, Oxford, UK.

Clare E Mackay (CE)

Department of Psychiatry, University of Oxford, Oxford, UK clare.mackay@psych.ox.ac.uk.
Oxford Health NHS Foundation Trust, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH